Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data

Funding Opportunity ID: 285237 Opportunity Number: 16-573 Opportunity Title: Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big DataOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCategory Explanation: CFDA Number(s): 47.04993.17293.17393.21393.24293.27393.27993.28693.35093.36193.39693.84693.84793.85393.85693.85993.86593.86693.86793.87993.989Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Additional Information on Eligibility: Agency Code: NSFAgency Name: National Science FoundationPosted Date: Jun 21, 2016Close Date: Sep 28, 2016Last Updated Date: Jun 21, 2016Award Ceiling: Award Floor: Estimated Total Program Funding: $5,000,000Expected Number of Awards: 20Description: Recent advances in medical and healthcare technologies are creating a paradigm shift in how medical practitioners and biomedical researchers approach the diagnosis, prevention, and treatment of diseases. New imaging technologies, advances in genetic testing, and innovations in wearable and/or ambient sensors are allowing researchers to predict health outcomes and develop personalized treatments or interventions. Coupled with the rapid growth in computing and infrastructure, researchers now have t...
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding

Related Links:

Called Winship at Midtown, the nearly $500 million building will consolidate cancer services and improve a patient's experience.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Abstract Human papillomaviruses (HPV) are small, double-stranded DNA viruses that cause cervical cancer, the second most lethal cancer among women in the world. Currently, two vaccines are on the market for preventing HPV-caused cervical cancers and warts. Both are virus-like particle (VLP)-based vaccines. However, these vaccines have limitations; they are costly, have an invasive route of administration, require trained personnel to administer, need cold chain storage to preserve them, and most of all, they are preventive vaccines that do not have curative effects. Therefore, it is necessary to develop therapeuti...
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Tags: J Pharm Pharm Sci Source Type: research
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Article Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Article Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Perspective Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Trends and Innovations Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Snapshot Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Best of the Rest Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Quiz Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Bone and Joint in Brief Source Type: news
More News: Computers | Environmental Health | Funding | Genetics | Grants | Health | National Institutes of Health (NIH) | Research | Science | Statistics | Study